Newborn DNA sequencing reveals parents' cancer risks; The best of ASCO

Plus: ImmunoGen drug prolongs survival of women with advanced ovarian cancer 

June 6, 2023 Check out STAT+

Sponsored By

Adobe 'We arguably saved their lives': Newborn DNA-sequencing reveals elevated cancer risks for parents Three mothers who learned they carried a gene that drastically elevated their cancer risks chose to undergo prophylactic surgeries. By Megan Molteni STAT+ | Gilead's CAR-T therapy prolongs survival in key blood cancer trial Yescarta is the first CAR-T to show longer survival for this blood cancer in a randomized study, another milestone for the therapy. By Adam Feuerstein Cross-border 'twinning programs' may reduce survival disparities for childhood leukemia After a San Diego hospital teamed up with one in Tijuana, more children in Mexico survived acute lymphoblastic leukemia, a study reports. By Angus Chen Marie Miller for STAT STAT+ | FDA oncology head wants advisory panels to keep voting on new drugs Richard Pazdur begs to differ with his boss, the commissioner, on the importance of recording the opinions of independent experts on approval. By Angus Chen STAT+ | ImmunoGen drug prolongs survival of women with advanced ovarian cancer Elahere is a type of drug that's increasingly popular for its ability to deliver tumor-killing chemotherapy directly where it's needed. By Adam Feuerstein STAT+ | Keytruda's benefits, a breast cancer win, the 'dom-zim doublet': Weekend wrap-up from ASCO Besides new data on the drugs Keytruda and Kisqali, pharma leaders took the chance to critique the Inflation Reduction Act. By Adam Feuerstein and Matthew Herper and Angus Chen

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser